News
Digitek - Defective Drug Litigation - Another drug Moore Landrey is watching closely is Digitek. On April 25, 2008, Digitek was recalled due to the possibility that tablets were doubled in thickness and could contain twice the appropriate level of the active ingredient. Digitek is a medication used to treat congestive heart failure, abnormal heart rhythms, and other conditions. If you or a loved-one suffered injury from Digitek, contact John Cowart at (512) 499-8900 or email him at jcowart@moorelandrey.com for a free consultation and to discuss your legal options.
Heparin - Defective Drug Litigation - Moore Landrey LLP is investigating cases of serious injury or death related to contaminated Heparin distributed in the United States. Major recalls of Heparin were announced by the U.S. Food & Drug Administration (FDA) in March 2008. The FDA said at least 395 deaths and 785 reports of serious injury were believed linked to a raw Heparin ingredient imported from China. If you suffered serious injury from contaminated Heparin contact John Cowart at (512) 499-8900 or email him at jcowart@moorelandrey.com for a free consultation and to discuss your legal options.
Trasylol - Defective Drug Litigation - We are investigating kidney failure cases associated with the Bayer drug Trasylol (Aprotinin). If a person underwent open heart surgery, they may have been given this drug to prevent excessive bleeding. If you or a loved one suffered kidney failure after open heart surgery, you may have a claim. Contact John Cowart at (512) 499-8900 or email him at jcowart@moorelandrey.com for a free consultation and to discuss your legal options.
Gadolinium - Defective Drug Litigation - Moore Landrey LLP is handling cases where injuries to kidneys were caused by MRI contrast dyes containing Gadolinium. These dyes are made by multiple manufacturers. Contact John Cowart at (512) 499-8900 or email him at jcowart@moorelandrey.com for a free consultation and to discuss your legal options if you believe that you or a loved one was injured by Gadolinium contrasting agents.